BeiGene Announces BRUKINSA (zanubrutinib) Is Approved in 50 Markets

13.06.2022 - BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide today announced that its BTK ... Seite 1

Related Keywords

Saudi Arabia ,Qatar ,Ministry Of Health ,Dubayy ,United Arab Emirates ,Kuwait ,Bahrain ,Abdul Aziz Hamadah ,National Health Regulatory Authority ,Head Of Hematology Department ,Ministry Of Public Health ,Newbridge Pharmaceuticals ,Kuwait Cancer Control Center ,Public Health ,Middle East ,North Africa ,Hematology Department ,Kuwait Cancer Control ,Beigene ,